randomized controlled study < randomized controlled trial < randomized controlled trial (RCT)

Facettes :

List of bibliographic references indexed by randomized controlled trial

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
001491 (2011)	Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas]	Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials
001D94 (2010)	Yoshikuni Mizuno [Japon] ; Kazuko Hasegawa [Japon] ; Tomoyoshi Kondo [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon]	Clinical efficacy of istradefylline (KW‐6002) in Parkinson's disease: A randomized, controlled study
002D46 (2007)	Dan A. Mendonça [Canada] ; Krishe Menezes [Canada] ; Mandar S. Jog [Canada]	Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial
002D92 (2007)	Teri R. Thomsen [Canada] ; Wendy R. Galpern [Canada, États-Unis] ; Abena Asante [Canada] ; Tamara Arenovich [Canada] ; Susan H. Fox [Canada]	Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "randomized controlled trial" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "randomized controlled trial" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    randomized controlled trial
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024